 MALVERN, Pa., June 23, 2021 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the company will be added to the Russell 2000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. 